Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Inflammation and oxidative stress pathways in macrophages and lung tissue represent a complex network of biological processes central to the pathogenesis of various respiratory diseases. In the lung, alveolar macrophages act as primary immune sentinels that, upon activation by pathogens or pollutants, initiate an inflammatory cascade by releasing cytokines such as Tumor necrosis factor-alpha (TNF-alpha) and Interleukin-6 (IL-6) (Life Sciences, 2021). Concurrently, these cells generate reactive oxygen species (ROS) through enzymes like NADPH oxidase, which, while intended for host defense, can cause significant collateral damage to lung parenchyma if left unchecked (Chest, 2017). This state of oxidative stress further amplifies inflammation by activating redox-sensitive transcription factors, most notably Nuclear factor-kappa B (NF-kappaB), creating a self-perpetuating cycle of tissue injury (Nature Reviews Immunology, 2017). Conversely, the Nuclear factor erythroid 2-related factor 2 (Nrf2) pathway serves as a critical counter-regulatory mechanism by inducing the expression of antioxidant enzymes to restore redox homeostasis (Annual Review of Pharmacology and Toxicology, 2013). Therapeutic targeting of these pathways involves a variety of approaches, including the use of corticosteroids to suppress cytokine production, N-acetylcysteine to replenish glutathione levels, and novel Nrf2 activators to enhance endogenous defenses (Expert Opinion on Therapeutic Targets, 2019). Because this entry describes a broad physiological process involving multiple molecular actors rather than a single protein or receptor, it is classified as a pathway or therapeutic area rather than a discrete molecular target (American Journal of Pathology, 2018).
Modulation of pro-inflammatory cytokine production, scavenging of reactive oxygen species, and induction of antioxidant gene expression via Nrf2 activation.
6 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Inflammation and oxidative stress pathways in macrophages and lung tissue.